OCULAR THERAPEUTIX, INC Operating Cash Flow
OCULAR THERAPEUTIX, INC (OCUL) reported Operating Cash Flow of -$133.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-03
- OCULAR THERAPEUTIX, INC net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$67.27M.
- OCULAR THERAPEUTIX, INC net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$65.99M.
- OCULAR THERAPEUTIX, INC net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$54.25M.
- OCULAR THERAPEUTIX, INC net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$50.73M.
- OCULAR THERAPEUTIX, INC net cash provided by (used in) operating activities for fiscal 2025 was -$204.88M.
- OCULAR THERAPEUTIX, INC net cash provided by (used in) operating activities for fiscal 2024 was -$134.68M.
- OCULAR THERAPEUTIX, INC net cash provided by (used in) operating activities for fiscal 2023 was -$70.23M.
- OCULAR THERAPEUTIX, INC net cash provided by (used in) operating activities for fiscal 2022 was -$59.60M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$67.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$133.26M 10-Q · filed 2026-08-03 | -$187.51M derived: sum of 3 quarters · filed 2026-08-03 | -$238.24M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$65.99M 10-Q · filed 2026-05-05 | -$120.24M derived: sum of 2 quarters · filed 2026-05-05 | -$170.97M derived: sum of 3 quarters · filed 2026-05-05 | -$226.21M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$54.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | -$104.97M derived: sum of 2 quarters · filed 2026-02-05 | -$160.21M derived: sum of 3 quarters · filed 2026-08-03 | -$204.88M 10-K · filed 2026-02-05 |
| 2025-09-30 | -$50.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$105.96M derived: sum of 2 quarters · filed 2026-08-03 | -$150.63M 10-Q · filed 2025-11-04 | -$190.06M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$55.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$99.91M 10-Q · filed 2026-08-03 | -$139.34M derived: sum of 3 quarters · filed 2026-08-03 | -$175.90M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$44.67M 10-Q · filed 2026-05-05 | -$84.10M derived: sum of 2 quarters · filed 2026-05-05 | -$120.66M derived: sum of 3 quarters · filed 2026-05-05 | -$145.46M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$39.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | -$75.99M derived: sum of 2 quarters · filed 2026-02-05 | -$100.79M derived: sum of 3 quarters · filed 2026-02-05 | -$134.68M 10-K · filed 2026-02-05 |
| 2024-09-30 | -$36.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$61.36M derived: sum of 2 quarters · filed 2025-11-04 | -$95.25M 10-Q · filed 2025-11-04 | -$117.70M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-06-30 | -$24.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$58.69M 10-Q · filed 2025-08-05 | -$81.14M derived: sum of 3 quarters · filed 2026-02-05 | -$88.88M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-03-31 | -$33.89M 10-Q · filed 2025-05-05 | -$56.34M derived: sum of 2 quarters · filed 2026-02-05 | -$64.07M derived: sum of 3 quarters · filed 2026-02-05 | -$84.15M derived: sum of 4 quarters · filed 2026-02-05 |
| 2023-12-31 | -$22.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-05 | -$30.19M derived: sum of 2 quarters · filed 2026-02-05 | -$50.26M derived: sum of 3 quarters · filed 2026-02-05 | -$70.23M 10-K · filed 2026-02-05 |
| 2023-09-30 | -$7.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$27.81M derived: sum of 2 quarters · filed 2024-11-14 | -$47.78M 10-Q · filed 2024-11-14 | -$64.74M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$20.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$40.05M 10-Q · filed 2024-08-07 | -$57.01M derived: sum of 3 quarters · filed 2025-03-03 | -$70.17M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$19.97M 10-Q · filed 2024-05-07 | -$36.93M derived: sum of 2 quarters · filed 2025-03-03 | -$50.10M derived: sum of 3 quarters · filed 2025-03-03 | -$60.98M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$16.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$30.13M derived: sum of 2 quarters · filed 2025-03-03 | -$41.00M derived: sum of 3 quarters · filed 2025-03-03 | -$59.60M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$13.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$24.05M derived: sum of 2 quarters · filed 2023-11-07 | -$42.65M 10-Q · filed 2023-11-07 | -$57.80M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | -$10.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$29.48M 10-Q · filed 2023-08-07 | -$44.63M derived: sum of 3 quarters · filed 2024-03-11 | -$57.61M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | -$18.60M 10-Q · filed 2023-05-08 | -$33.75M derived: sum of 2 quarters · filed 2024-03-11 | -$46.73M derived: sum of 3 quarters · filed 2024-03-11 | -$66.79M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | -$15.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$28.14M derived: sum of 2 quarters · filed 2024-03-11 | -$48.19M derived: sum of 3 quarters · filed 2024-03-11 | -$65.55M 10-K · filed 2024-03-11 |
| 2021-09-30 | -$12.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$33.04M derived: sum of 2 quarters · filed 2022-11-07 | -$50.40M 10-Q · filed 2022-11-07 | -$56.64M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | -$20.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$37.41M 10-Q · filed 2022-08-08 | -$43.66M derived: sum of 3 quarters · filed 2023-03-06 | -$57.32M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | -$17.36M 10-Q · filed 2022-05-09 | -$23.61M derived: sum of 2 quarters · filed 2023-03-06 | -$37.26M derived: sum of 3 quarters · filed 2023-03-06 | -$52.06M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | -$6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$19.90M derived: sum of 2 quarters · filed 2023-03-06 | -$34.70M derived: sum of 3 quarters · filed 2023-03-06 | -$53.55M 10-K · filed 2023-03-06 |
| 2020-09-30 | -$13.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$28.45M derived: sum of 2 quarters · filed 2021-11-08 | -$47.31M 10-Q · filed 2021-11-08 | -$66.78M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$14.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$33.65M 10-Q · filed 2021-08-09 | -$53.12M derived: sum of 3 quarters · filed 2022-02-28 | -$72.66M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$18.85M 10-Q · filed 2021-05-05 | -$38.32M derived: sum of 2 quarters · filed 2022-02-28 | -$57.87M derived: sum of 3 quarters · filed 2022-02-28 | -$77.05M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$19.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$39.01M derived: sum of 2 quarters · filed 2022-02-28 | -$58.19M derived: sum of 3 quarters · filed 2022-02-28 | -$77.58M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$19.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$38.73M derived: sum of 2 quarters · filed 2020-11-05 | -$58.11M 10-Q · filed 2020-11-05 | -$71.76M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$19.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$38.57M 10-Q · filed 2020-08-07 | -$52.22M derived: sum of 3 quarters · filed 2020-08-07 | -$63.09M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | -$19.39M 10-Q · filed 2020-05-08 | -$33.03M derived: sum of 2 quarters · filed 2020-05-08 | -$43.91M derived: sum of 3 quarters · filed 2020-05-08 | -$56.14M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | -$13.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$24.52M derived: sum of 2 quarters · filed 2020-03-12 | -$36.75M derived: sum of 3 quarters · filed 2020-03-12 | -$49.23M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$10.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$23.11M derived: sum of 2 quarters · filed 2019-11-12 | -$35.58M 10-Q · filed 2019-11-12 | -$45.96M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$12.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$24.71M 10-Q · filed 2019-08-07 | -$35.09M derived: sum of 3 quarters · filed 2020-03-12 | -$49.47M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$12.47M 10-Q · filed 2019-05-10 | -$22.86M derived: sum of 2 quarters · filed 2020-03-12 | -$37.24M derived: sum of 3 quarters · filed 2020-03-12 | -$48.37M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$10.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$24.77M derived: sum of 2 quarters · filed 2020-03-12 | -$35.90M derived: sum of 3 quarters · filed 2020-03-12 | -$50.47M 10-K · filed 2020-03-12 |
| 2017-09-30 | -$14.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$25.51M derived: sum of 2 quarters · filed 2018-11-07 | -$40.09M 10-Q · filed 2018-11-07 | -$47.70M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | -$11.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$25.71M 10-Q · filed 2018-08-07 | -$33.32M derived: sum of 3 quarters · filed 2019-03-07 | -$40.65M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$14.58M 10-Q · filed 2018-05-08 | -$22.19M derived: sum of 2 quarters · filed 2019-03-07 | -$29.52M derived: sum of 3 quarters · filed 2019-03-07 | |
| 2016-12-31 | -$7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$14.94M derived: sum of 2 quarters · filed 2019-03-07 | -$34.00M 10-K · filed 2019-03-07 | |
| 2016-09-30 | -$7.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$26.39M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | -$19.06M 10-Q · filed 2017-08-08 | |||
| 2015-12-31 | -$33.74M 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |